- JP-listed companies
- Fuji Pharma Co.,Ltd.
- Income statement
Fuji Pharma Co.,Ltd.【JP:4554】Income statement
Market cap
¥47.6B
P/E ratio
12.3x
| 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| Revenue | 21,623 | 21,520 | 25,174 | 29,215 | 31,680 | 34,229 | 35,387 | 37,909 | 36,279 | 33,793 | 33,990 | 35,426 | 40,889 | 46,138 | 51,677 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | 16,835 | 18,709 | 20,691 | 20,671 | 21,959 | 20,483 | 18,921 | 19,239 | 20,867 | 24,374 | 28,294 | 28,955 |
| Gross profit | - | - | - | 12,379 | 12,970 | 13,537 | 14,715 | 15,950 | 15,796 | 14,872 | 14,751 | 14,558 | 16,514 | 17,844 | 18,535 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | ||||||||||||
| Operating income | - | - | - | 3,173 | 3,251 | 3,568 | 4,314 | 4,391 | 4,173 | 3,139 | 3,349 | 3,777 | 3,858 | 3,880 | 4,990 |
| Operating expenses | - | - | - | 9,206 | 9,718 | 9,969 | 10,401 | 11,559 | 11,622 | 11,732 | 11,402 | 10,781 | 12,656 | 13,963 | 14,329 |
| Income before tax | 3,545 | 2,698 | 3,376 | 3,198 | 3,099 | 3,251 | 4,628 | 4,472 | 4,169 | 2,983 | 3,250 | 3,725 | 4,519 | 4,445 | 4,459 |
| Pretax margin (%) | 16.4 | 12.5 | 13.4 | 10.9 | 9.8 | 9.5 | 13.1 | 11.8 | 11.5 | 8.8 | 9.6 | 10.5 | 11.1 | 9.6 | 8.6 |
| Provision for income taxes | - | - | - | 1,153 | 1,012 | 1,029 | 1,228 | 1,099 | 998 | 832 | 938 | 1,026 | 963 | 2,128 | 789 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | 2,204 | 1,370 | 2,068 | 2,078 | 2,092 | 2,118 | 3,301 | 3,372 | 2,962 | 2,085 | 2,432 | 2,697 | 3,435 | 6,147 | 2,452 |
| Net income margin (%) | |||||||||||||||
| Earnings per share | 167.63 | 97.09 | 146.48 | 140.53 | 137.55 | 141.64 | 220.63 | 112.68 | 97.04 | 66.94 | 90.54 | 111.01 | 141.37 | 252.85 | 122.94 |
| Diluted EPS | 167.63 | 97.09 | 146.48 | 140.53 | 137.55 | 141.64 | 220.63 | 112.68 | 97.04 | 66.94 | 90.54 | 111.01 | 141.37 | 252.85 | 122.94 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | |||||||
| Dividend per share | - | - | - | - | - | - | - | - | 29 | 29 | 29 | 35 | 37 | 42.5 | 45.5 |
| EBITDA | - | - | - | ||||||||||||
| EBITDA margin (%) | - | - | - |